$CABA
Cabaletta Bio, Inc.

2023 Q1 Form 10-K Financial Statement

#000095017023008298 Filed on March 16, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.521M $3.902M $14.84M
YoY Change 18.07% -1.81% 7.38%
% of Gross Profit
Research & Development $12.44M $12.40M $39.30M
YoY Change 35.61% 25.01% 20.95%
% of Gross Profit
Depreciation & Amortization $365.0K $358.0K $1.178M
YoY Change 66.67% 52.99% 60.71%
% of Gross Profit
Operating Expenses $16.96M $16.30M $54.14M
YoY Change 30.44% 17.34% 66.61%
Operating Profit -$16.96M -$54.14M
YoY Change 30.44% 16.9%
Interest Expense $1.102M $610.0K $1.164M
YoY Change 1979.25% 12100.0% 4750.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$15.85M -$15.69M -$52.98M
YoY Change 22.46% 12.99% 14.44%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$15.85M -$15.69M -$52.98M
YoY Change 22.46% 12.99% 14.44%
Net Earnings / Revenue
Basic Earnings Per Share -$0.45 -$1.81
Diluted Earnings Per Share -$0.45 -$0.52 -$1.81
COMMON SHARES
Basic Shares Outstanding 31.34M 29.01M 5.942M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $93.85M $106.5M $106.5M
YoY Change -14.07% -12.83% -12.83%
Cash & Equivalents $93.85M $81.61M $81.61M
Short-Term Investments $0.00 $24.94M $24.94M
Other Short-Term Assets $1.889M $2.287M $2.287M
YoY Change -15.14% -1.38% -1.38%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $95.73M $108.8M $108.8M
YoY Change -14.09% -12.61% -12.61%
LONG-TERM ASSETS
Property, Plant & Equipment $2.593M $2.578M $7.569M
YoY Change 110.64% 79.28% 426.36%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $581.0K $565.0K $565.0K
YoY Change -41.02% 58.26% 58.26%
Total Long-Term Assets $7.713M $8.134M $8.134M
YoY Change 248.06% 353.15% 353.15%
TOTAL ASSETS
Total Short-Term Assets $95.73M $108.8M $108.8M
Total Long-Term Assets $7.713M $8.134M $8.134M
Total Assets $103.4M $117.0M $117.0M
YoY Change -8.98% -7.42% -7.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.955M $2.463M $2.463M
YoY Change 1.15% 5.57% 5.57%
Accrued Expenses $3.176M $5.694M $5.694M
YoY Change 256.45% 91.27% 91.27%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.305M $9.489M $9.489M
YoY Change 34.17% 13.23% 13.23%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.491M $2.959M $2.959M
YoY Change
Total Long-Term Liabilities $2.491M $2.959M $2.959M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $9.305M $9.489M $9.489M
Total Long-Term Liabilities $2.491M $2.959M $2.959M
Total Liabilities $11.80M $12.45M $12.45M
YoY Change 70.09% 48.54% 48.54%
SHAREHOLDERS EQUITY
Retained Earnings -$181.4M -$165.6M
YoY Change 44.52% 47.05%
Common Stock $273.1M $270.1M
YoY Change 17.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $91.65M $104.5M $104.5M
YoY Change
Total Liabilities & Shareholders Equity $103.4M $117.0M $117.0M
YoY Change -8.98% -7.42% -7.42%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$15.85M -$15.69M -$52.98M
YoY Change 22.46% 12.99% 14.44%
Depreciation, Depletion And Amortization $365.0K $358.0K $1.178M
YoY Change 66.67% 52.99% 60.71%
Cash From Operating Activities -$12.61M -$12.13M -$46.38M
YoY Change -1.57% 15.37% 35.98%
INVESTING ACTIVITIES
Capital Expenditures $380.0K $316.0K $2.453M
YoY Change 158.5% -309.27% 110.38%
Acquisitions
YoY Change
Other Investing Activities $25.00M $0.00 -$24.76M
YoY Change -150.24% -100.0% -445.62%
Cash From Investing Activities $24.62M -$316.0K -$27.22M
YoY Change -149.33% -137.22% -553.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $32.86M
YoY Change -31.91%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 226.0K 32.89M 32.98M
YoY Change 343.14% 141.35% -32.56%
NET CHANGE
Cash From Operating Activities -12.61M -12.13M -46.38M
Cash From Investing Activities 24.62M -316.0K -27.22M
Cash From Financing Activities 226.0K 32.89M 32.98M
Net Change In Cash 12.24M 20.44M -40.62M
YoY Change -119.53% 416.0% 44.49%
FREE CASH FLOW
Cash From Operating Activities -$12.61M -$12.13M -$46.38M
Capital Expenditures $380.0K $316.0K $2.453M
Free Cash Flow -$12.99M -$12.45M -$48.83M
YoY Change 0.25% 20.1% 38.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.81
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0139
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001759138
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 caba Change In State Tax Rate
ChangeInStateTaxRate
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-39103
CY2022 dei Entity Registrant Name
EntityRegistrantName
CABALETTA BIO, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-1685768
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
2929 Arch Street
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 600
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Philadelphia
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19104
CY2022 dei City Area Code
CityAreaCode
267
CY2022 dei Local Phone Number
LocalPhoneNumber
759-3100
CY2022 dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
CY2022 dei Trading Symbol
TradingSymbol
CABA
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
29000000
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31340989
CY2022 dei Auditor Firm
AuditorFirmId
42
CY2022 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2022 dei Auditor Location
AuditorLocation
Philadelphia, Pennsylvania
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81607000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
122222000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
24940000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
0
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2287000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2319000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
108834000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
124541000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2578000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1438000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4991000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
565000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
357000
CY2022Q4 us-gaap Assets
Assets
116968000
CY2021Q4 us-gaap Assets
Assets
126336000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2463000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2333000
CY2022Q4 caba Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
4847000
CY2021Q4 caba Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
6047000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2179000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9489000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8380000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2959000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2022Q4 us-gaap Liabilities
Liabilities
12448000
CY2021Q4 us-gaap Liabilities
Liabilities
8380000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29445134
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29445134
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28927129
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28927129
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
0
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
0
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
270129000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
230543000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-47000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-165562000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-112587000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
104520000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
117956000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
116968000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
126336000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39300000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32494000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14839000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13819000
CY2022 us-gaap Operating Expenses
OperatingExpenses
54139000
CY2021 us-gaap Operating Expenses
OperatingExpenses
46313000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-54139000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-46313000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
1164000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
24000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-52975000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-46289000
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-47000
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-53022000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-46289000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.81
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.81
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.80
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.80
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
109544000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
48253000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
579000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
71000
CY2021 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-6000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5804000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-46289000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
117956000
CY2022 caba Issuance Of Common Stock And Pre Funded Warrants For The Purchase Of Common Stock Net Of Issuance Costs
IssuanceOfCommonStockAndPreFundedWarrantsForThePurchaseOfCommonStockNetOfIssuanceCosts
126815
CY2022 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
32562000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
51000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
76000
CY2022 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-47000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6897000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-52975000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
104520000
CY2022 us-gaap Profit Loss
ProfitLoss
-52975000
CY2021 us-gaap Profit Loss
ProfitLoss
-46289000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
6897000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
5804000
CY2022 us-gaap Depreciation
Depreciation
1178000
CY2021 us-gaap Depreciation
Depreciation
733000
CY2022 caba Non Cash Lease Expense
NonCashLeaseExpense
2506000
CY2021 caba Non Cash Lease Expense
NonCashLeaseExpense
0
CY2022 us-gaap Accretion Expense
AccretionExpense
685000
CY2021 us-gaap Accretion Expense
AccretionExpense
0
CY2022 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
149000
CY2021 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0
CY2022 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
223000
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-62000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-32000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2554000
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
208000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
58000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-28000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
975000
CY2022 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1185000
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2110000
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2910000
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-46380000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34109000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2453000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1166000
CY2022 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
49764000
CY2021 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0
CY2022 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
25000000
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
7165000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27217000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5999000
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
32855000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
48253000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
51000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
579000
CY2022 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
76000
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
71000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
32982000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
48903000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-40615000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
20793000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
122222000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
101429000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
81607000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
122222000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
135000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13740000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2022 caba Derecognition Of Embedded Lease Upon Lease Amendment
DerecognitionOfEmbeddedLeaseUponLeaseAmendment
-6392000
CY2021 caba Derecognition Of Embedded Lease Upon Lease Amendment
DerecognitionOfEmbeddedLeaseUponLeaseAmendment
0
CY2022 us-gaap Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
293000
CY2021 us-gaap Noninterest Expense Offering Cost
NoninterestExpenseOfferingCost
0
CY2022Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
106547000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-165562000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying financial statements include but are not limited to the valuation allowance on the Company’s deferred tax assets and certain accruals. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2629000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2369000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1191000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2578000
CY2022Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P2Y6M
CY2022 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
0
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
106594000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
47000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
106547000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4947000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1438000
CY2022 us-gaap Depreciation
Depreciation
1178000
CY2021 us-gaap Depreciation
Depreciation
733000
CY2022Q4 caba Accrued Research And Development Services Current
AccruedResearchAndDevelopmentServicesCurrent
1194000
CY2021Q4 caba Accrued Research And Development Services Current
AccruedResearchAndDevelopmentServicesCurrent
2836000
CY2022Q4 caba Accrued General And Administrative Services Current
AccruedGeneralAndAdministrativeServicesCurrent
99000
CY2021Q4 caba Accrued General And Administrative Services Current
AccruedGeneralAndAdministrativeServicesCurrent
180000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3515000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2977000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
39000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
54000
CY2022Q4 caba Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
4847000
CY2021Q4 caba Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
6047000
CY2022Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P2Y6M
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7563000
CY2022 caba Gain On Derecognition Of Lease Asset And Liability
GainOnDerecognitionOfLeaseAssetAndLiability
149000
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.083
CY2022 us-gaap Lease Cost
LeaseCost
3849000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
3042000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
36000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2910000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
752000
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2279000
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Two
OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo
2286000
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Three
OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree
1146000
CY2022Q4 caba Lessee Undiscounted Lease Payments
LesseeUndiscountedLeasePayments
5711000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
573000
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
5138000
CY2019Q4 us-gaap Common Stock Conversion Features
CommonStockConversionFeatures
Each share of the Company’s non-voting common stock may be converted at any time into one share of common stock at the option of its holder by providing written notice to the Company
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0147
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0418
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0063
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0139
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.79
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.83
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.79
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.81
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
11559000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.079
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.125
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.045
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.044
CY2022 caba Effective Income Tax Rate Reconciliation Nondeductible Items And Other
EffectiveIncomeTaxRateReconciliationNondeductibleItemsAndOther
0.006
CY2021 caba Effective Income Tax Rate Reconciliation Nondeductible Items And Other
EffectiveIncomeTaxRateReconciliationNondeductibleItemsAndOther
0.006
CY2022 caba Change In State Tax Rate
ChangeInStateTaxRate
-0.074
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.254
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.373
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
28880000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
28857000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
5859000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
3359000
CY2022Q4 caba Capitalized Rd Costs
CapitalizedRDCosts
9640000
CY2021Q4 caba Capitalized Rd Costs
CapitalizedRDCosts
0
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3840000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2616000
CY2022Q4 caba Deferred Tax Assets License Fees Deductions
DeferredTaxAssetsLicenseFeesDeductions
262000
CY2021Q4 caba Deferred Tax Assets License Fees Deductions
DeferredTaxAssetsLicenseFeesDeductions
318000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1535000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
0
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1165000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
1074000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
51181000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
36224000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
49689000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
36224000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1492000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2022Q4 caba Operating Lease Assets
OperatingLeaseAssets
-1492000
CY2021Q4 caba Operating Lease Assets
OperatingLeaseAssets
0
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
13465
CY2022Q4 caba Deferred Tax Assets Operating Loss Carryforwards Federal
DeferredTaxAssetsOperatingLossCarryforwardsFederal
99174000
CY2022Q4 caba Deferred Tax Assets Operating Loss Carryforwards State
DeferredTaxAssetsOperatingLossCarryforwardsState
101359000
CY2022Q4 caba Deferred Tax Assets Operating Loss Carryforwards Local
DeferredTaxAssetsOperatingLossCarryforwardsLocal
82179000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
98924000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
250000
CY2022 caba Operating Loss Carryforwards Federal Commencement Of Expiration Date
OperatingLossCarryforwardsFederalCommencementOfExpirationDate
2037
CY2022 caba Operating Loss Carryforwards State Commencement Of Expiration Date
OperatingLossCarryforwardsStateCommencementOfExpirationDate
2037
CY2022 caba Operating Loss Carryforwards Local Commencement Of Expiration Date
OperatingLossCarryforwardsLocalCommencementOfExpirationDate
2023
CY2022 caba Percentage Of Eligible Tax Positions For Recognition
PercentageOfEligibleTaxPositionsForRecognition
0.50
CY2022Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5942036
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6013384
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4257213
CY2022 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.04
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
351000
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
256000

Files In Submission

Name View Source Status
caba-20221231_def.xml Edgar Link unprocessable
0000950170-23-008298-index-headers.html Edgar Link pending
0000950170-23-008298-index.html Edgar Link pending
0000950170-23-008298.txt Edgar Link pending
0000950170-23-008298-xbrl.zip Edgar Link pending
caba-20221231.htm Edgar Link pending
caba-20221231.xsd Edgar Link pending
caba-ex10_33.htm Edgar Link pending
caba-ex10_34.htm Edgar Link pending
caba-ex21_1.htm Edgar Link pending
caba-ex23_1.htm Edgar Link pending
caba-ex31_1.htm Edgar Link pending
caba-ex31_2.htm Edgar Link pending
caba-ex32_1.htm Edgar Link pending
caba-ex32_2.htm Edgar Link pending
caba-ex4_3.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
caba-20221231_lab.xml Edgar Link unprocessable
caba-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
caba-20221231_htm.xml Edgar Link completed
img62048493_0.jpg Edgar Link pending
img62048493_1.jpg Edgar Link pending
img62048493_2.jpg Edgar Link pending
img62048493_3.jpg Edgar Link pending
img62048493_4.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
caba-20221231_cal.xml Edgar Link unprocessable